REG - Tristel PLC - Notice of Preliminary Results

TristelAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250916:nRSP3576Za&default-theme=true

RNS Number : 3576Z  Tristel PLC  16 September 2025

TRISTEL plc

("Tristel" or the "Company")

 

Notice of Preliminary Results

Analyst & Investor briefing schedule

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that its preliminary results for the year ended 30 June 2025 will be
announced on Monday 13 October 2025.

 

Analyst briefing

A briefing open to analysts will take place in London on Monday 13 October
2025 at 9.30am. To register and for more details please contact Walbrook PR
on tristel@walbrookpr.com 

 

Investor presentation

Matt Sassone, CEO, and Anna Wasyl, CFO, will present the Company's results in
two separate events open to all investors. The same presentation will be given
at both events which are being held at different times to offer convenient
options for those wishing to attend.

 

Two presentations will take place on Monday 13 October 2025 at the
following times, the first will be held online via the Investor Meet Company
platform and the second will be held in-person in the City of London, full
details below:

 

1.    Investor Meet Company online presentation

Tristel management will provide a live online presentation relating to
the preliminary results via Investor Meet Company at 11.30am. The
presentation is open to all existing and potential shareholders. Questions can
be submitted pre-event via your Investor Meet Company dashboard up until 9am
the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to
meet Tristel plc via:

https://www.investormeetcompany.com/tristel-plc/register-investor
(https://www.investormeetcompany.com/tristel-plc/register-investor)

 

2.    In-person investor presentation

Tristel management will provide an in-person presentation relating to the
Company's preliminary results at 4.30pm, which is open to all existing and
potential shareholders. The Company welcomes investors from 4.15pm for a
4.30pm start and will be followed by refreshments.

 

If you would like to attend, please contact Walbrook PR for more details on
020 7933 8780 or email tristel@walbrookpr.com.

 

The results presentation will be made available on the Company's website on
the day of results - https://investors.tristel.com/
(https://investors.tristel.com/)

 

 

For further information please contact:

 Tristel plc                                                                Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                      https://investors.tristel.com/ (https://investors.tristel.com/)
 Anna Wasyl, Chief Financial Officer

 Walbrook PR Ltd                                                            Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus / Lianne Applegarth / Anna Dunphy    Mob: 07980 541 893/ 07584 391 303/ 07876 741 001

 Cavendish Capital Markets Ltd                                              Tel: 020 7220 0500
 Geoff Nash / Callum Davidson/Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 270 people across 16
subsidiaries selling into 40+ countries. The Company targets double digit
revenue growth annually and an EBITDA margin of at least 25% and the business
is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORLAMMTMTTBBFA